1.Predictors of a Shorter Time to Hospitalization in Patients with Bipolar Disorder: Medication during the Acute and Maintenance Phases and Other Clinical Factors.
In Hee SHIM ; Young Sup WOO ; Hee Ryung WANG ; Won Myong BAHK
Clinical Psychopharmacology and Neuroscience 2017;15(3):248-255
OBJECTIVE: The present study was conducted to compare the effects of pharmacological treatments during the acute and maintenance phases of mood episodes, sociodemographic, and clinical characteristics between a shorter time to hospitalization group (<12 months) and a longer time to hospitalization group (≥12 months). METHODS: The discharge medication for the first hospitalization was considered the acute treatment and the medication used during the week prior to the second hospitalization at the outpatient clinic was considered the maintenance treatment. Additionally, the charts were reviewed to examine a variety of demographic and clinical characteristics. RESULTS: Patients in the shorter time to hospitalization group were more likely to be unmarried and/or unemployed, have had a previous hospital admission for a mood episode, and have used antidepressant during the acute phase than those in the longer time to hospitalization group. Patients in the shorter time to hospitalization group were also less likely to use olanzapine, serotonin-norepinephrine reuptake inhibitors, or mood stabilizer monotherapy as a maintenance treatment than were patients in the longer time to hospitalization group. CONCLUSION: Predictors for shorter time to hospitalization were associated with number of previous hospital admissions for a mood episode, being unmarried and/or unemployed, and antidepressant use during the acute phase.
Ambulatory Care Facilities
;
Bipolar Disorder*
;
Hospitalization*
;
Humans
;
Prescriptions
;
Single Person
2.Management of depression and suicide.
Hyeon Woo YIM ; Hyunsuk JEONG ; Young Eun JUNG ; Hee Ryung WANG ; Soo Young KIM
Journal of the Korean Medical Association 2011;54(3):275-283
Depression is a highly prevalent mental health disease that, fortunately, can easily be treated. However, depression is often inadequately managed because only some depressive patients seek professional help, and even when they do, they often discontinue their treatments. Research has shown that there is a high association between suicide and depression. Proper depression management plans help depressive patients adhere to treatment medication and support them in continuing treatment. These efforts for treating depression may reduce suicidal ideation and behavior. Simply giving screening results to clinicians was not enough to have treatment outcomes. Besides informing clinicians of patients' screening results, staff-assisted care, including educating patients, following-up on assessments and treatment schedules, helping patients adhere to prescribed antidepressant medications, and referring to mental health care professionals would be critical to achieving successful treatment outcomes. A higher level of staff-assisted care has been reported to have higher treatment outcomes. Future studies in Korea are needed to establish a depression screening system, including post-screening management programs in primary care or community care settings, and to assess the effectiveness of this system. Attaining a higher depression diagnosis rate through screening and running post-screening management programs with sufficient staffing for treatment adherence will reduce depression relapse and suicidal attempts.
Appointments and Schedules
;
Depression
;
Humans
;
Korea
;
Mass Screening
;
Mental Health
;
Primary Health Care
;
Recurrence
;
Running
;
Suicidal Ideation
;
Suicide
3.One-Year Rehospitalization Rates of Inpatients with First-Episode Bipolar Mania Treated with Atypical Antipsychotics in Combination with Mood Stabilizers: A Preliminary Study.
Young Eun JUNG ; Hoo Rim SONG ; Hee Ryung WANG ; Tae Youn JUN ; Won Myong BAHK
Korean Journal of Psychopharmacology 2010;21(3):137-143
OBJECTIVE: We compared the one-year rehospitalization rates of first-episode bipolar manic patients who were discharged while being treated with atypical antipsychotics in combination with mood stabilizers. METHODS: We monitored the rehospitalization status of the first-episode bipolar manic patients who were discharged between 1 January 2003 and 31 December 2008 while they were taking risperidone (n=34), olanzapine (n=26) or quetiapine (n=32) in combination with mood stabilizers. Rehospitalizations were tracked over a 1-year period using the Kaplan-Meier method and Cox regression model was used to analyze covariates thought to affect time to rehospitalization. RESULTS: The rehospitalization rates during the 1-year follow-up period for patients taking atypical antipsychotics plus mood stabilizers were 22.8% (n=21). There were no significant differences in rehospitalization estimated using the Kaplan-Meier formula among the patients treated with risperidone (29.4%), olanzapine (23.1%) or quetiapine (15.6%). The psychotic symptoms, previous depressive episodes, lower Global Assessment of Functioning (GAF) score at discharge and less length of first hospitalization contributed to the risk of rehospitalization. CONCLUSION: The 1-year rehospitalization rates of first-episode bipolar manic patients taking risperidone, olanzapine, or quetiapine do not differ and the psychotic symptoms and previous depressive episodes affect time to rehospitalization.
Antipsychotic Agents
;
Benzodiazepines
;
Bipolar Disorder
;
Dibenzothiazepines
;
Follow-Up Studies
;
Hospitalization
;
Humans
;
Inpatients
;
Risperidone
;
Track and Field
;
Quetiapine Fumarate
4.Effect of Dawn Simulation on Difficulty Awakening in the Morning and Daytime Sleepiness in Adolescents with Delayed Sleep Phase Syndrome.
Shi Hyun KANG ; Hanik K YOO ; Seockhoon CHUNG ; Hee Ryung WANG ; Joon Ho AHN ; In Young YOON ; Chang Yoon KIM
Journal of Korean Neuropsychiatric Association 2007;46(6):546-551
OBJECTIVES: Delayed sleep phase syndrome (DSPS) is characterized by difficulties in falling asleep and waking up at a desired time. Dawn simulation is a technique using a light that gradually increases in intensity before awakening in the morning, to imitate a natural sunrise. It has been found to be effective in decreasing both morning drowsiness and difficulty in awakening as well as treating symptoms of seasonal affective disorder. The aim of this study was to determine whether dawn simulation is helpful in decreasing difficulty in morning awakening and daytime sleepiness in adolescents with DSPS. METHODS: Twelve adolescents with DSPS participated in a 2-week dawn simulation trial. Each subject self-assessed level of difficulty in awakening, morning drowsiness and daytime sleepiness during a 2-week baseline period and a following 2-week trial period with dawn simulator. Subjects used Stanford Sleepiness Scale (SSS) for measuring morning drowsiness and Epworth Sleepiness Scale (ESS) for measuring daytime sleepiness. Difficulty in awakening was assessed by a single-item questionnaire. RESULTS: Dawn simulation trial decreased morning drowsiness (p=0.016) and daytime sleepiness (p=0.013) significantly compared to baseline. It also seemed to improve difficulty in awakening, but the effect was not statistically significant (p=0.092). CONCLUSION: Dawn simulation may help waking up in the morning and may improve daytime functioning by deceasing both morning drowsiness and daytime sleepiness in adolescents with DSPS.
Adolescent*
;
Humans
;
Surveys and Questionnaires
;
Seasonal Affective Disorder
;
Sleep Disorders, Circadian Rhythm*
;
Sleep Stages
5.The Validation Study of the Korean Version of the Bipolar Spectrum Diagnostic Scale.
Hee Ryung WANG ; Sangeok KIM ; Shi Hyun KANG ; Yeon Ho JOO ; Chang Yoon KIM
Journal of Korean Neuropsychiatric Association 2008;47(6):533-539
OBJECTIVES: Because bipolar spectrum disorders frequently go unrecognized in clinical practice, sensitive screening tools for bipolar spectrum disorders are much needed. This study was conducted to confirm the validity of the Korean version of the Bipolar Spectrum Diagnostic Scale (BSDS), which was originally designed by Ronald Pies. METHODS: The BSDS, which was translated into Korean by the authors, was administered to patients with known bipolar disorders (N=60) and unipolar depressive disorders (N=27). Using various cut-off scores, we calculated the sensitivities and specificities of the Korean version of the BSDS in order to determine the optimal cut-off score. RESULTS: In this study, a cut-off score of 10 was shown to be optimal, with a sensitivity of 0.73 and a specificity of 0.85, although a cut-off score of 13 was proposed to be optimal by the original authors of the BSDS. CONCLUSION: These results indicate that the Korean version of the BSDS is a valid screening tool for bipolar spectrum disorder.
Bipolar Disorder
;
Depressive Disorder
;
Depressive Disorder, Major
;
Humans
;
Mass Screening
;
Sensitivity and Specificity
6.Agomelatine: The Novel Antidepressant.
Young Sup WOO ; Hee Ryung WANG ; Won Myong BAHK
Korean Journal of Psychopharmacology 2014;25(1):1-10
Major depression is a common mental illness, associated with high morbidity and mortality. Antidepressants have been the first-line therapies due to their confirmed efficacy, however, considering high rate of poor treatment response to these therapies, distressing side effects, and delayed onset of their efficacy, there has been much effort to find alternative treatments for major depression. Recently, evidence regarding disturbed circadian rhythms involved in the pathophysiology of major depression has emerged, the interest on this area has been increasing. Agomelatine is an emerging antidepressant, with a unique profile of selective antagonist at serotonin 2C (5-HT2C) receptors and melatonin receptor agonist. Previous studies have shown its superior efficacy over placebo in treating major depression. Previous trials have shown comparable antidepressant efficacy of agomelatine compared to other standard antidepressants including venlafaxine, sertraline, and fluoxetine. Regarding safety profile of agomelatine, it seems to be not associated with sexual dysfunction and it has less potential for serotonin syndrome or discontinuation syndrome than standard antidepressants including selective serotonin reuptake inhibitors. Considering favorable results on the efficacy and safety of agomelatine in treating depression, it could be a good, safe treatment alternative in the treatment of depression.
Antidepressive Agents
;
Circadian Rhythm
;
Depression
;
Fluoxetine
;
Mortality
;
Receptors, Melatonin
;
Serotonin
;
Serotonin Syndrome
;
Serotonin Uptake Inhibitors
;
Sertraline
;
Venlafaxine Hydrochloride
7.Difference in Treatment Outcome in Hospitalized Major Depression Patients with versus without Anxious Distress Specifier in DSM-5.
Su Wan KIM ; Hee Ryung WANG ; Young Sup WOO ; Tae Youn JUN ; Won Myong BAHK
Korean Journal of Psychopharmacology 2015;26(1):22-28
OBJECTIVE: In Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), a new specifier of major depressive disorder (MDD) "with anxious distress" allows characterization of additional symptoms. The aim of this study was to investigate difference in treatment outcome of MDD with versus without anxious distress specifier in DSM-5. METHODS: Retrospective chart review of patients admitted to a university hospital with a primary diagnosis of MDD in a period from March 2013 to September 2014 was conducted. We reviewed anxious distress symptoms, medications and detailed clinical information at index episode. We compared treatment outcomes of anxious distress group with those of non anxious distress group. RESULTS: There were differences in remission rate after 4 weeks later (18.5% vs. 44.4%, p=0.040) and at discharge (33.3% vs. 66.7%, p=0.014) between anxious distress and non anxious distress. However, no significant differences were observed in the sociodemographic characteristics, treatment regimens, and response rate. CONCLUSION: Anxious distress specifier might be worthwhile to be further evaluated as a diagnostic entity of its own requiring specific diagnosis and therapeutic attention.
Depression*
;
Depressive Disorder, Major
;
Diagnosis
;
Diagnostic and Statistical Manual of Mental Disorders
;
Humans
;
Retrospective Studies
;
Treatment Outcome*
8.Psychiatric Manifestations and Risk Factors in Children with Seizure Disorders.
Hee Ryung WANG ; Hanik K YOO ; Mi Sun YUM ; Tae Sung KO
Journal of Korean Epilepsy Society 2007;11(1):40-49
PURPOSE: This study was aimed to investigate the psychiatric manifestations in children with epilepsy and the associations with seizure-related variables. METHODS: The Korean version of the Child Behavior Checklist (K-CBCL) and the ADHD Rating Scale (K-ARS) were used to assess the psychopathology of 78 children with epilepsy (39 boys, mean age: 9.8+/-3.26 years-old) and 78 healthy comparisons matched for age and sex. RESULTS: Compared with healthy comparisons, children with epilepsy showed differences in the social, school, total competence scale, withdrawn, somatic complaints, social problems, thought, attention problems, aggressive behavior, internalizing and externalizing problem, and total behavior problem scores in the K-CBCL. Significant differences in the social, school, total competence scale, withdrawn, social problems, attention, and total behavior problem scales were found between groups in clinical spectrum and nonclinical spectrum. The inattentive, hyperactive/impulsive, and total scores of the K-ARS between groups were significantly different. In addition, the total scores of the K-ARS between subjects in clinical spectrum and nonclinical spectrum were different. The more the number of antiepileptic drugs, the higher significance of the score for aggressive behavior, sex problem, somatic complaints in the K-CBCL, and the inattentive scales in the K-ARS. In addition, the withdrawn, anxious/depressed and somatic complaints in the K-CBCL were correlated with sex, onset age and seizure type, respectively. CONCLUSIONS: Children with epilepsy may experience more various and serious psychiatric problems than healthy children. Responsiveness to antiepileptic drugs and seizure itself can be risk factors of psychiatric manifestations in epileptic children.
Age of Onset
;
Anticonvulsants
;
Checklist
;
Child Behavior
;
Child*
;
Epilepsy*
;
Humans
;
Mental Competency
;
Psychopathology
;
Risk Factors*
;
Seizures*
;
Sexual Behavior
;
Social Problems
;
Weights and Measures
9.The Influence of Current Mood States on Screening Accuracy of the Mood Disorder Questionnaire
Hee Ryung WANG ; Won-Myong BAHK ; Bo-Hyun YOON ; Moon-Doo KIM ; Young-Eun JUNG ; Kyung Joon MIN ; Jeongwan HONG ; Young Sup WOO
Clinical Psychopharmacology and Neuroscience 2020;18(1):25-31
Objective:
In this study we investigated whether current mood states of patients with bipolar disorder have an influence on the screening accuracy of the Mood Disorder Questionnaire (MDQ).
Methods:
A total of 452 patients with mood disorder (including 192 with major depressive disorder and 260 with bipolar disorder completed the Korean version of the MDQ. Patients with bipolar disorder were subdivided into three groups (bipolar depressed only, bipolar euthymic only, bipolar manic/hypomanic only) according to current mood states. The screening accuracy of the MDQ including sensitivity, specificity and area under the curve (AUC) of receiver operating characteristic (ROC) curves were evaluated according to current mood states.
Results:
The optimal cutoff of MDQ was 5 in this study sample. Sensitivity and specificity were not significantly different according to current mood states. Significant differences in AUCs of four independent ROC curves were not found (ROC 1st curve included all bipolar patients; ROC 2nd curve included only bipolar depressed patients; ROC 3rd curve included only bipolar manic/hypomanic patients; ROC 4th curve included only bipolar euthymic patients).
Conclusion
The study results showed that current mood states (either euthymic state, depressed or manic/hypomanic) did not significantly influence the screening accuracy of the MDQ suggesting that the MDQ could be a useful screening instrument for detecting bipolar disorder in clinical practice regardless of the current mood symptoms of subjects.
10.Maternal Parenting Stress and Sense of Competence in Children with Seizure Disorders.
Subin PARK ; Hanik K YOO ; Jeongwon JEON ; Soon Ho CHOI ; Hee Ryung WANG ; Kunwoo KIM ; Jin Yong KIM ; Tae Sung KO
Journal of Korean Neuropsychiatric Association 2007;46(6):596-602
OBJECTIVES: While parents who foster children with epilepsy would have considerable parenting difficulties, the parenting stress and sense of competence have not been investigated. We investigated maternal parenting stress, parenting satisfaction and sense of parenting competence in children with seizure disorders, and the associations with seizure-related variables. METHODS: Mothers of 79 children with seizure disorders (41 boys, 38 girls; mean age, 9.9+/-2.3 years) and 79 healthy comparison subjects matched for age and sex were recruited for this study. The Korean version of the Parenting Stress Index (K-PSI-SF) and the Parenting Sense of Competence (K-PSOC) were used to assess parenting stress, parenting satisfaction and parenting efficacy. RESULTS: Mothers of children with seizure disorders showed higher scores on stress related to difficult child and child learning and parenting anxiety compared to mothers of healthy children. In addition, scores on stress related to parental-child interaction and child learning were significantly associated with parental economic status. Scores on stress from parental-child interaction was also correlated with seizure severity, and stress from child learning was correlated with seizure type. Sense of parenting competence and anxiety scores were correlated with paternal educational status, respectively. CONCLUSION: These findings suggest that mothers of children with epilepsy have greater parenting stress and anxiety and social and seizure-associated factors may affect the parenting stress and anxiety.
Anxiety
;
Child*
;
Educational Status
;
Epilepsy*
;
Female
;
Humans
;
Learning
;
Mental Competency*
;
Mothers
;
Parenting*
;
Parents*
;
Seizures*